Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy

New England Journal of Medicine

Volumn 335, Issue 9, 1996, Pages 624-630

  Zhou, Yi Fu ^a   Leon, Martin B ^b   Waclawiw, Myron A ^a   Popma, Jeffery J ^b   Yu, Zu Xi ^a   Finkel, Toren ^a   Epstein, Stephen E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; VIRUS DNA;

ADULT; AGED; ARTERY DIAMETER; ARTICLE; ATHERECTOMY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; RISK ASSESSMENT;

ADULT; AGED; ANTIBODIES, VIRAL; ATHERECTOMY, CORONARY; CINEANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEPATITIS ANTIBODIES; HEPATOVIRUS; HUMANS; IMMUNOGLOBULIN G; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; SEROLOGIC TESTS;

EID: 0029840904     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199608293350903     Document Type: Article

References (31)

1. Serruys PW, Luijten HE, Beatt KJ, et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon: a quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988;77:361-71.
2. Faxon DP, Currier JW. Prevention of post-PTCA restenosis. Ann N Y Acad Sci 1995;748:419-27.
3. Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994;265:391-4.
4. Melnick JL, Adam E, Debakey ME. Cytomegalovirus and atherosclerosis. Eur Heart J 1993;14:Suppl K:30-8.
5. Jordan MC, Rousseau WE, Stewart JA, Noble GR, Chin TDY. Spontaneous cytomegalovirus mononucleosis: clinical and laboratory observations in nine cases. Ann Intern Med 1973;79:153-60.
6. Klacsmann P. Cytomegalovirus mononucleosis. Del Med J 1977;49: 399-409.
7. Bruggeman CA. Cytomegalovirus and latency: an overview. Virchows Arch B Cell Pathol Incl Mol Pathol 1993;64:325-33.
8. Banks TA, Rouse BT. Herpesvirus - immune escape artists? Clin Infect Dis 1992;14:933-41.
9. Jacobson MA, Mills J. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS): clinical findings, diagnosis, and treatment. Ann Intern Med 1988;108:585-94.
10. Schulman LL, Reison DS, Austin JHM, Rose EA. Cytomegalovirus pneumonitis after cardiac transplantation. Arch Intern Med 1991;151: 1118-24.
11. Southern P, Oldstone MBA. Medical consequences of persistent viral infection. N Engl J Med 1986;314:359-67.
12. Geist LJ, Monick MM, Stinski MF, Hunninghake GW. The immediate early genes of human cytomegalovirus upregulate expression of the interleukin-2 and interleukin-2 receptor genes. Am J Respir Cell Mol Biol 1991; 5:292-6.
13. Bach R, Jung F, Kohsiek I, et al. Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty. Thromb Res 1994; 74:Suppl 1:S55-S67.
14. Hermans WRM, Rensing BJ, Foley DP, et al. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. J Cardiovasc Pharmacol 1993;22:Suppl 4:S45-S57.
15. Le Feuvre CL, Bonan R, Lesperance J, Gosselin G, Joyal M, Crepeau J. Predictive factors of restenosis after multivessel percutaneous transluminal coronary angioplasty. Am J Cardiol 1994;73:840-4.
16. Dzavik V, Teo KK, Yokoyama S, et al. Effect of serum lipid concentrations on restenosis after successful de novo percutaneous transluminal coronary angioplasty in patients with total cholesterol 160 to 240 mg/dl and triglycerides <350 mg/dl. Am J Cardiol 1995;75:936-8.
17. Stein B, Weintraub WS, Gebhart SP, et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 1995;91:979-89.
18. Foley DP, Melkert R, Serruys PW. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty. Circulation 1994;90:1239-51.
19. Gonczol E, Plotkin SA. Cells infected with human cytomegalovirus release a factor(s) that stimulates cell DNA synthesis. J Gen Virol 1984;65: 1833-7.
20. Alcami J, Barzu T, Michelson S. Induction of an endothelial cell growth factor by human cytomegalovirus infection of fibroblasts. J Gen Virol 1991;72:2765-70.
21. Kowalik TF, Wing B, Haskill JS, Azizkhan JC, Baldwin AS Jr, Huang ES. Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Immunology 1993;78:405-12.
22. Grundy JE, Downes KL. Up-regulation of LFA-3 and ICAM-I on the surface of fibroblasts infected with cytomegalovirus. Immunology 1993; 78:405-12.
23. O'Brien KD, Allen MD, McDonald TO, et al. Vascular cell adhesion molecule-I is expressed in human coronary atherosclerotic plaques: implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993;92:945-51.
24. Span AH, van Dam-Mieras MC, Mullers W, Endert J, Muller AD, Bruggeman CA. The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells. Eur J Clin Invest 1991;21:331-8.
25. Etingin OR, Silverstein RL, Hajjar DP. von Willebrand factor mediates platelet adhesion to virally infected endothelial cells. Proc Natl Acad Sci USA 1993;90:5153-6.
26. van Dam-Mieras MCE, Muller AD, van Hinsbergh VWM, Mullers WJ, Bomans PH, Bruggeman CA. The procoagulant response of cytomegalovirus infected endothelial cells. Thromb Haemost 1992;68:364-70.
27. Etingin OR, Silverstein RL, Friedman HM, Hajjar DP Viral activation of the coagulation cascade: molecular interactions at the surface of infected endothelial cells. Cell 1990;61:657-62.
28. Pryzdial ELG, Wright JF. Prothrombinase assembly on an enveloped virus: evidence that the cytomegalovirus surface contains procoagulant phospholipid. Blood 1994;84:3749-57.
29. Zhou YF, Guetta E, Yu ZX, Finkel T, Epstein SE. Human cytomegalovirus, through its immediate early gene product IE72, directly activates transcription of the scavenger receptor gene in human aortic smooth muscle cells. Circulation 1995;92:Suppl I:I-162. abstract.
30. Zhu H, Shen Y, Shenk T. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol 1995;69:7960-70.
31. Zhou YF, Shou M, Guzman R, Guetta E, Finkel T, Epstein SE. Cytomegalovirus infection increases neointimat formation in the rat model of balloon injury. J Am Coll Cardiol 1995;25(Special Issue):242a. abstract.